Predictors of ICS/LABA prescribing in COPD patients: a study from general practice

BMC Primary Care

Table 4 Agreement between actual prescribing of ICS/LABA for 59 COPD patients (FEV ₁ /FVC < 0.7) with no concomitant diagnosis of asthma in 2009/10 and the prescribing recommended based on the 2011 GOLD guidelines

	ICS/LABA recommended (FEV₁% predicted < 50 or previous exacerbation)
ICS/LABA	Yes	No
prescribed 2009/10
Yes	14	9	23
No	17	19	36
	31^a	28	59
	Kappa = 0.13 (SE 0.12)

^aFrequent exacerbation only was recorded in eight patients, predicted FEV₁% <50% only in 12 patients, and both findings in 11 patients.

ISSN: 2731-4553